Intellia Therapeutics, Inc. · 1 day ago
Senior Director, Alliance Management
Cambridge, MA
Full-time
Hybrid
Director/Executive
$258K/yr - $315K/yr
12+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe and life-threatening diseases. The Senior Director, Alliance Management will lead strategic partnerships and licensing agreements, ensuring alignment with the company's objectives and maximizing the value of its late-stage assets.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Work closely with the Executive Leadership Team, Program Leadership, R&D, and Commercial teams to ensure alignment of alliance management activities with the company's strategic and operational objectives
Collaborate with BD, program / project teams, and functional leadership to assess the feasibility and execution of partnerships and alliance deliverables
Work with prospective, new and existing partners to ensure that Intellia and the partner achieve the goals of the alliance
Accountable for coordinating effective communication and governance, in line with both the letter and spirit of the alliance governance provisions. Directly manage joint governance committees, ensure proactive preparation with appropriate stakeholders, and timely documentation and dissemination of detailed, accurate, and actionable meeting minutes
Understand joint roles, responsibilities, and processes to proactively engage on decisions. Serve as the initial point of contact for conflict resolution and exercise sound judgement in escalation of key issues and risks as unexpected events emerge
Develop and maintain a comprehensive knowledge of each contract and associated contracts, ensuring internal and external parties are adhering to their obligations across all aspects of the alliance
While keeping a close eye on the contractual commitments and boundaries, maintain a wider perspective and continually consider the principles, spirit, and long-term goals of the alliance to ensure we are always driving towards those objectives
Identify issues and opportunities that are 'extra-contractual' and work both in Intellia and with the partner to construct a path forward to address or capitalize on them
Coordinate external communication plans and execution to ensure critical information is shared in timely manner and to enable each party to effectively communicate with third parties in a meaningful manner
Partner with legal on alliance renegotiation as opportunities for improvement arise. Actively participate in the process and decision-making around the conclusion of alliances, including potential expansion/extension of a collaboration, when they reach the end of their term or any other termination event
In collaboration with legal and R&D, coordinate progress reports for in-licensed IP and reviews for external-facing manuscripts and presentations that are relevant to partnerships
Manages colleagues involved in the Alliance process through a matrixed/dotted line role (strong influence skills required)
The role will lead Alliance Management within the broader department of Strategic Operations, Program & Alliance Management and may directly manage or oversee future alliance managers, as appropriate, based on scope and expansion of partnerships
Qualification
Required
Strong leadership, strategic thinking, and decision-making skills
Exceptional communication and negotiation skills, with the ability to influence stakeholders at all levels and across company lines
Ability to work in a fast-paced, dynamic environment and manage multiple priorities
Strong network of industry contacts and proven ability to build relationships with key decision-makers
Excellent business acumen, with the ability to assess and balance opportunities with risk
Desire and ability to perform both at a strategic leadership level as well as in a hands-on capacity as a player/coach
Thorough understanding of contracts
Understanding of the drug development process and working knowledge of the essential activities for all key functional areas
Excellent interpersonal, oral, and written communication skills, including specifically, the skills needed to manage difficult conversations and resolve conflicts as they arise
Develop a strong understanding of our research platform, in-vivo and/or ex-vivo capabilities and pipeline
Ability to work with scientific team members at all levels
Advanced degree in life sciences (e.g., MS, PhD) required, MBA a plus
Minimum 12+ years of experience within the biotechnology or pharmaceutical industry, and at least 5+ years of experience in roles within alliance management / program management
Proven track record of managing successful commercial partnerships, ideally global alliances. Prior experience with early R&D alliances
Experience in negotiating licensing and contract amendments for strategic alliances
Deep understanding of the biotechnology and healthcare sectors, with multidisciplinary knowledge across research, development, and commercialization
Prolonged periods of sitting at a desk and working on a computer
Ability to travel onsite or to in-person governance meetings with partners
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
2025-12-29
EIN Presswire
2025-11-26
Company data provided by crunchbase